Hellman L - Search Results

1

Generation of therapeutic antibody responses against IgE in dogs, an animal species with exceptionally high plasma IgE levels.

Ledin A, Bergvall K, Hillbertz NS, Hansson H, Andersson G, Hedhammar A, Hellman L. Ledin A, et al. Among authors: hellman l. Vaccine. 2006 Jan 9;24(1):66-74. doi: 10.1016/j.vaccine.2005.07.052. Epub 2005 Aug 10. Vaccine. 2006. PMID: 16169131

2

Generation of therapeutic antibody responses against IgE through vaccination.

Vernersson M, Ledin A, Johansson J, Hellman L. Vernersson M, et al. Among authors: hellman l. FASEB J. 2002 Jun;16(8):875-7. doi: 10.1096/fj.01-0879fje. Epub 2002 Apr 10. FASEB J. 2002. PMID: 11967231

3

Identification of adjuvants that enhance the therapeutic antibody response to host IgE.

Johansson J, Ledin A, Vernersson M, Lövgren-Bengtsson K, Hellman L. Johansson J, et al. Among authors: hellman l. Vaccine. 2004 Jul 29;22(21-22):2873-80. doi: 10.1016/j.vaccine.2003.12.029. Vaccine. 2004. PMID: 15246623

4

Modifications increasing the efficacy of recombinant vaccines; marked increase in antibody titers with moderately repetitive variants of a therapeutic allergy vaccine.

Johansson J, Hellman L. Johansson J, et al. Among authors: hellman l. Vaccine. 2007 Feb 19;25(9):1676-82. doi: 10.1016/j.vaccine.2006.10.055. Epub 2006 Nov 13. Vaccine. 2007. PMID: 17150285

5

High plasma IgE levels within the Scandinavian wolf population, and its implications for mammalian IgE homeostasis.

Ledin A, Arnemo JM, Liberg O, Hellman L. Ledin A, et al. Among authors: hellman l. Mol Immunol. 2008 Apr;45(7):1976-80. doi: 10.1016/j.molimm.2007.10.029. Epub 2007 Nov 26. Mol Immunol. 2008. PMID: 18036664

6

Therapeutic vaccines against IgE-mediated allergies.

Hellman L. Hellman L. Expert Rev Vaccines. 2008 Mar;7(2):193-208. doi: 10.1586/14760584.7.2.193. Expert Rev Vaccines. 2008. PMID: 18324889 Free article. Review.

7

Identification of potent biodegradable adjuvants that efficiently break self-tolerance--a key issue in the development of therapeutic vaccines.

Ringvall M, Huijbers EJ, Ahooghalandari P, Alekseeva L, Andronova T, Olsson AK, Hellman L. Ringvall M, et al. Among authors: hellman l. Vaccine. 2009 Dec 10;28(1):48-52. doi: 10.1016/j.vaccine.2009.09.122. Epub 2009 Oct 25. Vaccine. 2009. PMID: 19835827

8

The non-toxic and biodegradable adjuvant Montanide ISA 720/CpG can replace Freund's in a cancer vaccine targeting ED-B--a prerequisite for clinical development.

Huijbers EJ, Femel J, Andersson K, Björkelund H, Hellman L, Olsson AK. Huijbers EJ, et al. Among authors: hellman l. Vaccine. 2012 Jan 5;30(2):225-30. doi: 10.1016/j.vaccine.2011.11.010. Epub 2011 Nov 10. Vaccine. 2012. PMID: 22079080

9

Characterization of an experimental vaccine for bovine respiratory syncytial virus.

Hägglund S, Hu K, Blodörn K, Makabi-Panzu B, Gaillard AL, Ellencrona K, Chevret D, Hellman L, Bengtsson KL, Riffault S, Taylor G, Valarcher JF, Eléouët JF. Hägglund S, et al. Among authors: hellman l. Clin Vaccine Immunol. 2014 Jul;21(7):997-1004. doi: 10.1128/CVI.00162-14. Epub 2014 May 14. Clin Vaccine Immunol. 2014. PMID: 24828093 Free PMC article.

10

Profound reduction in allergen sensitivity following treatment with a novel allergy vaccine.

Hellman L. Hellman L. Eur J Immunol. 1994 Feb;24(2):415-20. doi: 10.1002/eji.1830240222. Eur J Immunol. 1994. PMID: 8299691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters